A Highly Efficient and Robust In Vitro Translation System for Expression of Picornavirus and Hepatitis C Virus RNA Genomes

Methods in Enzymology

Volumn 429, Issue , 2007, Pages 53-82

  Svitkin, Yuri V ^a   Sonenberg, Nahum ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL EXTRACT; NONSTRUCTURAL PROTEIN 3; NUCLEASE; PROTEINASE INHIBITOR; VIRUS RNA; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; CELL FREE SYSTEM; ENCEPHALOMYOCARDITIS VIRUS; FEMALE; HEPATITIS C VIRUS; IN VITRO STUDY; ISOTOPE LABELING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN TRANSPORT; PROTEINASE INHIBITION; REVIEW; RNA REPLICATION; VIRUS GENOME; VIRUS REPLICATION; VIRUS TRANSCRIPTION; ANIMAL; ARTICLE; CARCINOMA; GLYCOSYLATION; METABOLISM; PHYSIOLOGY; PROTEIN SYNTHESIS;

ENCEPHALOMYOCARDITIS VIRUS; HEPATITIS C VIRUS; PICORNAVIRIDAE;

ANIMALS; CARCINOMA, KREBS 2; CELL-FREE SYSTEM; ENCEPHALOMYOCARDITIS VIRUS; FEMALE; GENOME, VIRAL; GLYCOSYLATION; HEPACIVIRUS; MICE; PROTEIN BIOSYNTHESIS; RNA, VIRAL; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

EID: 36248948743     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0076-6879(07)29004-4     Document Type: Chapter

References (64)

1. Agol V.I. Picornavirus genome: An overview. In: Semler B.L., and Wimmer E. (Eds). "Molecular Biology of Picornaviruses" (2002), ASM Press, Washington, DC 127-148
2. Aviv H., Boime I., and Leder P. Protein synthesis directed by encephalomyocarditis virus RNA: Properties of a transfer RNA-dependent system. Proc. Natl. Acad. Sci. USA 68 (1971) 2303-2307
3. Bartenschlager R., Frese M., and Pietschmann T. Novel insights into hepatitis C virus replication and persistence. Adv. Virus Res. 63 (2004) 71-180
4. Barton D.J., Black E.P., and Flanegan J.B. Complete replication of poliovirus in vitro: Preinitiation RNA replication complexes require soluble cellular factors for the synthesis of VPg-linked RNA. J. Virol. 69 (1995) 5516-5527
5. Pol, and authentic RNA replication in HeLa S10 extracts. Methods Enzymol. 275 (1996) 35-57
6. Barton D.J., Morasco B.J., Smerage L.E., and Flanegan J.B. Poliovirus RNA replication and genetic complementation in cell-free reactions. In: Semler B.L., and Wimmer E. (Eds). "Molecular Biology of Picornaviruses" (2002), ASM Press, Washington, DC 461-469
7. Bonner W.M. Use of fluorography for sensitive isotope detection in polyacrylamide gel electrophoresis and related techniques. Methods Enzymol. 96 (1983) 215-222
8. Bordeleau M.E., Mori A., Oberer M., Lindqvist L., Chard L.S., Higa T., Belsham G.J., Wagner G., Tanaka J., and Pelletier J. Functional characterization of IRESes by an inhibitor of the RNA helicase eIF4A. Nat. Chem. Biol. 2 (2006) 213-220
9. Burness A.T. Purification of encephalomyocarditis virus. J. Gen. Virol. 5 (1969) 291-303
10. Dorner A.J., Semler B.L., Jackson R.J., Hanecak R., Duprey E., and Wimmer E. In vitro translation of poliovirus RNA: Utilization of internal initiation sites in reticulocyte lysate. J. Virol. 50 (1984) 507-514
11. Dubuisson J., Hsu H.H., Cheung R.C., Greenberg H.B., Russell D.G., and Rice C.M. Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses. J. Virol. 68 (1994) 6147-6160
12. Fata-Hartley C.L., and Palmenberg A.C. Dipyridamole reversibly inhibits mengovirus RNA replication. J. Virol. 79 (2005) 11062-11070
13. Giachetti C., and Semler B.L. Role of a viral membrane polypeptide in strand-specific initiation of poliovirus RNA synthesis. J. Virol. 65 (1991) 2647-2654
14. Gorbalenya A.E., Svitkin Y.V., Kazachkov Y.A., and Agol V.I. Encephalomyocarditis virus-specific polypeptide p22 is involved in the processing of the viral precursor polypeptides. FEBS Lett. 108 (1979) 1-5
15. Herold J., and Andino R. Poliovirus requires a precise 5′ end for efficient positive-strand RNA synthesis. J. Virol. 74 (2000) 6394-6400
16. Jackson R.J. A detailed kinetic analysis of the in vitro synthesis and processing of encephalomyocarditis virus products. Virology 149 (1986) 114-127
17. Jackson R.J. Potassium salts influence the fidelity of mRNA translation initiation in rabbit reticulocyte lysates: Unique features of encephalomyocarditis virus RNA translation. Biochim. Biophys. Acta 1088 (1991) 345-358
18. Jackson R.J., and Hunt T. Preparation and use of nuclease-treated rabbit reticulocyte lysates for the translation of eukaryotic messenger RNA. Methods Enzymol. 96 (1983) 50-74
19. Jang S.K., Kräusslich H.G., Nicklin M.J., Duke G.M., Palmenberg A.C., and Wimmer E. A segment of the 5′ nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J. Virol. 62 (1988) 2636-2643
20. Kato T., Furusaka A., Miyamoto M., Date T., Yasui K., Hiramoto J., Nagayama K., Tanaka T., and Wakita T. Sequence analysis of hepatitis C virus isolated from a fulminant hepatitis patient. J. Med. Virol. 64 (2001) 334-339
21. Kaufman R.J. The double-stranded RNA-activated protein kinase PKR. In: Sonenberg N., Hershey J.W.B., and Mathews M.B. (Eds). "Translational Control of Gene Expression" (2000), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY 503-527
22. Kerr I.M., and Martin E.M. Simple method for the isolation of encephalomyocarditis virus ribonucleic acid. J. Virol. 9 (1972) 559-561
23. Kerr I.M., Cohen N., and Work T.S. Factors controlling amino acid incorporation by ribosomes from Krebs II mouse ascites-tumour cells. Biochem. J. 98 (1966) 826-835
24. Lin C., Lindenbach B.D., Pragai B.M., McCourt D.W., and Rice C.M. Processing in the hepatitis C virus E2-NS2 region: Identification of p7 and two distinct E2-specific products with different C termini. J. Virol. 68 (1994) 5063-5073
25. Lindenbach B.D., and Rice C.M. Flaviviridae: the viruses and their replication. In: Knipe D.M., and Howley P.M. (Eds). "Fields Virology" Vol. 1 (2001), Lippincott Williams & Wilkins, Philadelphia, PA 991-1042
26. Lindenbach B.D., Evans M.J., Syder A.J., Wolk B., Tellinghuisen T.L., Liu C.C., Maruyama T., Hynes R.O., Burton D.R., McKeating J.A., and Rice C.M. Complete replication of hepatitis C virus in cell culture. Science 309 (2005) 623-626
27. Maley F., Trimble R.B., Tarentino A.L., and Plummer Jr. T.H. Characterization of glycoproteins and their associated oligosaccharides through the use of endoglycosidases. Anal. Biochem. 180 (1989) 195-204
28. Martin E.M., Malec J., Sved S., and Work T.S. Studies on protein and nucleic acid metabolism in virus-infected mammalian cells. 1. Encephalomyocarditis virus in Krebs II mouse-ascites-tumour cells. Biochem. J. 80 (1961) 585-597
29. Mathews M., and Korner A. Mammalian cell-free protein synthesis directed by viral ribonucleic acid. Eur. J. Biochem. 17 (1970) 328-338
30. Mikami S., Kobayashi T., Yokoyama S., and Imataka H. A hybridoma-based in vitro translation system that efficiently synthesizes glycoproteins. J. Biotechnol. 127 (2006) 65-78
31. Mikami S., Masutani M., Sonenberg N., Yokoyama S., and Imataka H. An efficient mammalian cell-free translation system supplemented with translation factors. Protein Expr. Purif. 46 (2006) 348-357
32. Molla A., Paul A.V., and Wimmer E. Cell-free, de novo synthesis of poliovirus. Science 254 (1991) 1647-1651
33. Moradpour D., Brass V., Bieck E., Friebe P., Gosert R., Blum H.E., Bartenschlager R., Penin F., and Lohmann V. Membrane association of the RNA-dependent RNA polymerase is essential for hepatitis C virus RNA replication. J. Virol. 78 (2004) 13278-13284
34. Munroe D., and Jacobson A. mRNA poly(A) tail, a 3′ enhancer of translational initiation. Mol. Cell. Biol. 10 (1990) 3441-3455
35. Novak J.E., and Kirkegaard K. Improved method for detecting poliovirus negative strands used to demonstrate specificity of positive-strand encapsidation and the ratio of positive to negative strands in infected cells. J. Virol. 65 (1991) 3384-3387
36. Palmenberg A.C., Pallansch M.A., and Rueckert R.R. Protease required for processing picornaviral coat protein resides in the viral replicase gene. J. Virol. 32 (1979) 770-778
37. Paul A.V. Possible unifying mechanism of picornavirus genome replication. In: Semler B.L., and Wimmer E. (Eds). "Molecular Biology of Picornaviruses" (2002), ASM Press, Washington, DC 227-246
38. Pause A., Kukolj G., Bailey M., Brault M., Do F., Halmos T., Lagace L., Maurice R., Marquis M., McKercher G., Pellerin C., Pilote L., et al. An NS3 serine protease inhibitor abrogates replication of subgenomic hepatitis C virus RNA. J. Biol. Chem. 278 (2003) 20374-20380
39. Pelham H.R.B. Translation of encephalomyocarditis virus RNA in vitro yields an active proteolytic processing enzyme. Eur. J. Biochem. 85 (1978) 457-462
40. Pelham H.R., and Jackson R.J. An efficient mRNA-dependent translation system from reticulocyte lysates. Eur. J. Biochem. 67 (1976) 247-256
41. Pelletier J., and Sonenberg N. Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 334 (1988) 320-325
42. Pestova T.V., Shatsky I.N., Fletcher S.P., Jackson R.J., and Hellen C.U. A prokaryotic-like mode of cytoplasmic eukaryotic ribosome binding to the initiation codon during internal translation initiation of hepatitis C and classical swine fever virus RNAs. Genes Dev. 12 (1998) 67-83
43. Reed K.E., and Rice C.M. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr. Top. Microbiol. Immunol. 242 (2000) 55-84
44. Rueckert R.R., and Pallansch M.A. Preparation and characterization of encephalomyocarditis (EMC) virus. Methods Enzymol. 78 (1981) 315-325
45. Sambrook J., Fritsch E.F., and Maniatis T. "Molecular Cloning: A Laboratory Manual,". 2nd ed. (1989), Cold Spring Harbor Laboratory Press,, Cold Spring Harbor, NY
46. Schmidt-Rose T., and Jentsch T.J. Transmembrane topology of a CLC chloride channel. Proc. Natl. Acad. Sci. USA 94 (1997) 7633-7638
47. Selby M.J., Glazer E., Masiarz F., and Houghton M. Complex processing and protein:protein interactions in the E2:NS2 region of HCV. Virology 204 (1994) 114-122
48. Svitkin Y.V., and Agol V.I. Complete translation of encephalomyocarditis virus RNA and faithful cleavage of virus-specific proteins in a cell-free system from Krebs-2 cells. FEBS Lett. 87 (1978) 7-11
49. Svitkin Y.V., and Sonenberg N. Cell-free synthesis of encephalomyocarditis virus. J. Virol. 77 (2003) 6551-6555
50. Svitkin Y.V., and Sonenberg N. An efficient system for cap- and poly(A)-dependent translation in vitro. Methods Mol. Biol. 257 (2004) 155-170
51. Svitkin Y.V., Gorbalenya A.E., Kazachkov Y.A., and Agol V.I. Encephalomyocarditis virus-specific polypeptide p22 possessing a proteolytic activity: Preliminary mapping on the viral genome. FEBS Lett. 108 (1979) 6-9
52. Svitkin Y.V., Ugarova T.Y., Chernovskaya T.V., Lyapustin V.N., Lashkevich V.A., and Agol V.I. Translation of tick-borne encephalitis virus (flavivirus) genome in vitro: Synthesis of two structural polypeptides. Virology 110 (1981) 26-34
53. Svitkin Y.V., Ovchinnikov L.P., Dreyfuss G., and Sonenberg N. General RNA binding proteins render translation cap dependent. EMBO J. 15 (1996) 7147-7155
54. Svitkin Y.V., Hahn H., Gingras A.C., Palmenberg A.C., and Sonenberg N. Rapamycin and wortmannin enhance replication of a defective encephalomyocarditis virus. J. Virol. 72 (1998) 5811-5819
55. Svitkin Y.V., Herdy B., Costa-Mattioli M., Gingras A.C., Raught B., and Sonenberg N. Eukaryotic translation initiation factor 4E availability controls the switch between cap-dependent and internal ribosomal entry site-mediated translation. Mol. Cell. Biol. 25 (2005) 10556-10565
56. Svitkin Y.V., Pause A., Lopez-Lastra M., Perreault S., and Sonenberg N. Complete translation of the hepatitis C virus genome in vitro: Membranes play a critical role in the maturation of all virus proteins except for NS3. J. Virol. 79 (2005) 6868-6881
57. Tan S.L., Pause A., Shi Y., and Sonenberg N. Hepatitis C therapeutics: Current status and emerging strategies. Nat. Rev. Drug Discov. 1 (2002) 867-881
58. Tsukiyama-Kohara K., Iizuka N., Kohara M., and Nomoto A. Internal ribosome entry site within hepatitis C virus RNA. J. Virol. 66 (1992) 1476-1483
59. Tsantrizos Y.S., Bolger G., Bonneau P., Cameron D.R., Goudreau N., Kukolj G., LaPlante S.R., Llinas-Brunet M., Nar H., and Lamarre D. Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection. Angew. Chem. Int. Ed. 42 (2003) 1356-1360
60. Villa-Komaroff L., McDowell M., Baltimore D., and Lodish H.F. Translation of reovirus mRNA, poliovirus RNA and bacteriophage Qb RNA in cell-free extracts of mammalian cells. Methods Enzymol. 30 (1974) 709-723
61. Villa-Komaroff L., Guttman N., Baltimore D., and Lodish H.F. Complete translation of poliovirus RNA in a eukaryotic cell-free system. Proc. Natl. Acad. Sci. USA 72 (1975) 4157-4161
62. Wakita T., Pietschmann T., Kato T., Date T., Miyamoto M., Zhao Z., Murthy K., Habermann A., Krausslich H.G., Mizokami M., Bartenschlager R., and Liang T.J. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11 (2005) 791-796
63. Walter P., and Blobel G. Preparation of microsomal membranes for cotranslational protein translocation. Methods Enzymol. 96 (1983) 84-93
64. Yanagi M., Purcell R.H., Emerson S.U., and Bukh J. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee. Proc. Natl. Acad. Sci. USA 94 (1997) 8738-8743